CVS vs PATH
CVS Health Corp (CVS) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CVS and PATH stock pages for the full models.
Not investment advice.